Scripps researchers modify vancomycin to make it more potent

Scientists at The Scripps Research Institute (TSRI) have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate the threat of antibiotic-resistant infections for years to come. The researchers, led by Dale Boger, co-chair of TSRI's Department of Chemistry, discovered a way to structurally modify vancomycin to make an already-powerful version ["]

The post Scripps researchers modify vancomycin to make it more potent appeared first on Outbreak News Today.